Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
635 - For APS having only two surfaces (i.e. a double-sided card), can you confirm if market benefit claims can appear on side 1, with the indication appearing on side 2?
-
The two surfaces of a two-sided card are generally considered to be equally prominent surfaces if the card is not appended to anything dictating a “front” or “back” side. In this scenario, the indication would be acceptable on either side, regardless of the positioning of marketing benefit claim. If the card is appended to something or formatted in a way that dictates a front/back designation (i.e. a letter), then the indication is required to appear on the front side if it contains a marketing claim other than those listed in section 1.5 of the PAAB code.
